OPRX OptimizeRx Corporation
Healthcare$4.83+0.00%OpenMarket Cap: $90.6M
As of 2026-05-26
Valuation
P/E (TTM)
24.31
PEG
0.19
P/B
0.72
P/S
0.86
EV/EBITDA
5.12
DCF Value
$-12.92
FCF Yield
15.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
69.0%
Operating Margin
13.6%
Net Margin
6.4%
ROE
5.5%
ROA
4.1%
ROIC
6.5%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $19.8M | 69.9% | $396.0K | $-495.0K | $— | — |
| Q4 null | $32.2M | 74.8% | $8.9M | $5.0M | $— | — |
| FY null | $109.4M | 63.3% | $12.1M | $5.1M | $— | — |
| Q3 null | $26.1M | 67.2% | $2.0M | $779.0K | $— | — |
| Q2 null | $29.2M | 63.8% | $3.2M | $1.5M | $— | — |
| Q1 null | $21.9M | 60.9% | $-2.1M | $-2.2M | $— | — |
| Q4 null | $32.3M | 68.1% | $3.6M | $-78.0K | $— | — |
| FY null | $92.1M | 64.5% | $-13.7M | $-20.1M | $— | — |
| Q3 null | $21.3M | 63.1% | $-8.6M | $-9.1M | $— | — |
| Q2 null | $18.8M | 62.2% | $-3.7M | $-4.0M | $— | — |
| Q1 null | $19.7M | 62.0% | $-5.0M | $-6.9M | $— | — |
| Q4 2023 | $28.4M | 62.9% | $-10.9M | $-4.1M | $-0.23 | — |